Scientific work

Prof. Dr. Evrim Metcalfe

21 publications. The source of the information is stated next to each publication.

Back to profile

  1. Gorken IB, Bayman E, Balci P, et al. Comparing Ultrasound with Computerized Tomography Images to Choose Electron Energy for Radiotherapy Boost Field in Breast Cancer Patients with Breast Conserving Surgery. J BUON. 2010;15(3):500-503.

    Source: medicana.com.tr profile page

  2. Etiz D, Bayman E, Akcay M, et al. Dosimetric and Clinical Predictors of Acute Esophagitis in Lung Cancer Patients in Turkey Treated with Radiotherapy. Asian Pac J Cancer Prev. 2013;14(7):4223-4228.

    Source: medicana.com.tr profile page

  3. Etiz D, Ataizi FC, Bayman E, et al. Prognostic Value of Osteopontin in Patients Treated with Primary Radiotherapy for Head and Neck Cancer. Asian Pac J Cancer Prev. 2013;14(9):5175-5178.

    Source: medicana.com.tr profile page

  4. Erpolat OP, Alco G, Caglar HB, et al. Comparison of Hematologic Toxicity Between 3DCRT and IMRT Planning in Cervical Cancer Patients After Concurrent Chemoradiotherapy: A National Multi-Center Study. Eur J Gynaecol Oncol. 2014;35(1):62-66.

    Source: medicana.com.tr profile page

  5. Bayman E, Prestwich RJ, Speight R, et al. Patterns of Failure After Intensity-Modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma Using Compartmental Clinical Target Volume Delineation. Clin Oncol (R Coll Radiol). 2014;26(10):636-642.

    Source: medicana.com.tr profile page

  6. Bayman E, Etiz D, Akcay M, Ak G. Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey. Asian Pac J Cancer Prev. 2014;15(15):6264-6267.

    Source: medicana.com.tr profile page

  7. Murray L, Sethugavalar B, Robertshaw H, Bayman E, et al. Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks. Clin Oncol (R Coll Radiol). 2015;27(7):401-410.

    Source: medicana.com.tr profile page

  8. Bird D, Scarsbrook AF, Sykes J, et al. Multimodality Imaging with CT, MR and FDG-PET for Radiotherapy Target Volume Delineation in Oropharyngeal Squamous Cell Carcinoma. BMC Cancer. 2015;15:844.

    Source: medicana.com.tr profile page

  9. Metcalfe E, Etiz D. Early Transient Radiation-Induced Brachial Plexopathy in Locally Advanced Head and Neck Cancer. Contemp Oncol (Pozn). 2016;20(1):67-72.

    Source: medicana.com.tr profile page

  10. Metcalfe E, Karaoglanoglu O, Akyazici E. Radiotherapy with or without Temozolomide in Elderly Patients Aged ≥70 Years with Glioblastoma. Contemp Oncol (Pozn). 2016;20(3):251-255.

    Source: medicana.com.tr profile page

  11. Metcalfe E, Aspin L, Speight R, et al. Postoperative (Chemo)Radiotherapy for Oral Cavity Squamous Cell Carcinomas: Outcomes and Patterns of Failure. Clin Oncol (R Coll Radiol). 2017;29(1):51-59.

    Source: medicana.com.tr profile page

  12. Etiz D, Metcalfe E, Akcay M. Multiple Primary Malignant Neoplasms: A 10-Year Experience at a Single Institution from Turkey. J Cancer Res Ther. 2017;13(1):16-20.

    Source: medicana.com.tr profile page

  13. Metcalfe E, Arik D, Oge T, et al. CD105 (Endoglin) Expression as a Prognostic Marker of Angiogenesis in Squamous Cell Cervical Cancer Treated with Radical Radiotherapy. J Cancer Res Ther. 2018;14(6):1373-1378.

    Source: medicana.com.tr profile page

  14. Oktay E, Levent M, et al. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): A Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). J Cancer Educ. 2020;35(1):69-75.

    Source: medicana.com.tr profile page

  15. Sert F, Metcalfe E, et al. Evaluation of the Radiation Oncologists’ Awareness and Needs about Geriatric Oncology: TROD-13-001 Study. Turk J Oncol. 2023;38(3):295-300. DOI:10.5505/tjo.2023.3978.

    Source: medicana.com.tr profile page

  16. Guzeloz Z, Gorken IB, et al. Evaluation of Treatment Outcomes and Tolerability in Older Patients with Rectal Cancer Treated with Radiotherapy Accompanied by the G-8 Geriatric Score: TROD13-003 Multicenter Study. J Geriatr Oncol. 2024;15(3):101739.

    Source: medicana.com.tr profile page

  17. Cetin IA, Halis H, et al. Definitive Radiotherapy/Chemoradiotherapy Outcomes and Toxicity Profile in Geriatric Patients with Cervical Cancer: Turkish Society for Radiation Oncology Geriatric Oncology Group Study (TROD 013-002). European Journal of Gynaecological Oncology. 2025;46(11):49-59. DOI:10.22514/ejgo.2025.137.

    Source: medicana.com.tr profile page

  18. Çağlar M, Akçay K, et al. Surface Dose Analysis and Dosimetric Comparison of Halcyon Versus Truebeam in Breast Cancer Radiotherapy: An OSL Dosimetry Study. J Appl Clin Med Phys. 2025:e70085. DOI:10.1002/acm2.70085.

    Source: medicana.com.tr profile page

  19. Çağlar M, Ertaş KS, et al. Synthetic CT Generation from CBCT Using Deep Learning for Adaptive Radiotherapy in Prostate Cancer. Front Radiol. 2025;5:1680803.

    Source: medicana.com.tr profile page

  20. Kirli Bolukbas M, Metcalfe E, et al. Determining Elderly-Friendly Radiation Oncology Clinics: A Comparative Analysis of Accessibility and Transport, Physical Environment, and Privacy Aspects (TROD 013-005). BMC Geriatr. 2025;26(1):118.

    Source: medicana.com.tr profile page

  21. Ergen ŞA, Dinçbaş FÖ, Metcalfe E, et al. Failure Patterns and the Influence of the TNM Staging Systems on Prognosis in Limited Disease Small Cell Lung Cancer (SCLC): The Turkish Oncology Group (TOG) Study. Clin Transl Oncol. 2025. DOI:10.1007/s12094-025-04092-9.

    Source: medicana.com.tr profile page